Titus Kretzschmar Person-Info 

( Ich bin Titus Kretzschmar)

News

(1 - 4 von 18
)

In Vitro and In Vivo Efficacy of DLX1008Technology Networks

www.technologynetworks.com
— ... Titus Kretzschmar, PhD, Chief Scientific Officer of Delenex. "Given the flexibility of the platform, in addition to advancing DLX

Leiden Declaration FDOFDO 2022

www.fdo2022.org
TItus Kretzschmar. Naturalis Biodiversity Center. Gabriel Preuß. Helmholtz-Zentrum Berlin für Materialien und Energie. András Micsik. SZTAKI. Harry van Haaften.

Delenex Expands Pipeline

www.startupticker.ch
... high potency with a favorable safety profile and cost-efficiency”, commented Titus Kretzschmar, PhD, Chief Scientific Officer at Delenex.

1abtik ag 설립···패혈증 치료 항체 신약 개발 목적뉴스와이어

www.newswire.co.kr
— 티투스 크레추마어(Titus Kretzschmar), PhD 설립자/CEO . 이 뉴스는 회사가 작성해 제공한 보도자료입니다. 뉴스와이어 ...
Dossier exportieren
+1